Loading...
10 results
Search Results
Now showing 1 - 10 of 10
- Biodegradation of fluoroquinolones by single bacteriaPublication . Amorim, Catarina L.; Moreira, Irina S.; Maia, Alexandra; Tiritan, Maria E.; Castro, Paula M. L.
- Pharmaceuticals biodegradation by activated sludge and pure culturesPublication . Bessa, Vânia S.; Moreira, Irina S.; Maia, Alexandra S.; Tiritan, Maria E.; Castro, Paula M. L.The occurrence of pharmaceuticals in the environment have been a topic of increasing concern. Most of the pharmaceuticals are not completely mineralized in the human body and are released on the sewage systems as the pharmaceutical itself and as their “biologically active” metabolites through excretion, as well as by improper elimination and disposal. Once current wastewater treatment plants (WWTPs) are not designed to remove these emerging pollutant, they are easily released into the environment.The effects of halogen on biological properties of molecules have had a marked impact on various fields such as pharmacology. It can improve metabolic stability, bioavailability and interactions with the biological target. However, it also increases the recalcitrance of the molecule to biotic and abiotic degradation. Ciprofloxacin (CPF) and Diclofenac (DCF) are two widely used halogenated pharmaceuticals, commonly found in the environment in concentrations that can range ng L−1 to mg L−1. CPF is a common human and veterinary broad-spectrum fluoroquinolone antibiotic. DCF is a non-steroidal anti-inflammatory drug (NSAID), also used as analgesic and antithermic treatment. In the present study, biodegradation of CPF and DCF was assessed by selective enrichements with actived sludge and with pure cultures of three different strains - Labrys portucalensis (F11) and two Rhodococcus spp. (FP1 and S2) – which had previously demonstrated capacity to degrade a range of halogenated compounds. For CPF selective enrichments, a degradation of 100% was achived after 206 days, although without fluoride release. These findings indicate that these selective enrichments are good candidates to find a bacterial strain able to biodegrade CPF. Regarding the pure cultures, F11 exhibited the highest degradation capacity (57%) after 62 days, but also without fluoride release. Concerning DCF selective enrichments, it was released 68% of the stoichiometrically expected cloride ion behind 131 days. In the experiments with pure cultures, F11 and S2, was released the totality of the stoichiometrically expected cloride, elapsed 131 days. These results indicate that these two strains are promising for DCF biodegradation.
- Biodegradation of ofloxacin, norfloxacin, and ciprofloxacin as single and mixed substrates by Labrys portucalensis F11Publication . Amorim, Catarina L.; Moreira, Irina S.; Maia, Alexandra S.; Tiritan, Maria E.; Castro, Paula M. L.Fluoroquinolone (FQ) antibiotics are extensively used both in human and veterinary medicine, and their accumulation in the environment is causing an increasing concern. In this study, the biodegradation of the three most worldwide used FQs, namely ofloxacin, norfloxacin, and ciprofloxacin, by the fluoroorganic-degrading strain Labrys portucalensis F11 was assessed. Degradation occurred when the FQs were supplied individually or as mixture in the culture medium, in the presence of an easily degradable carbon source. Consumption of individual FQs was achieved at different extents depending on its initial concentration, ranging from 0.8 to 30 μM. For the lowest concentration, total uptake of each FQ was observed but stoichiometric fluoride release was not achieved. Intermediate compounds were detected and identified by LC-MS/MS with a quadrupole time of flight detector analyzer. Biotransformation of FQs by L. portucalensis mainly occurred through a cleavage of the piperazine ring and displacement of the fluorine substituent allowing the formation of intermediates with less antibacterial potency. FQ-degrading microorganisms could be useful for application in bioaugmentation processes towards more efficient removal of contaminants in wastewater treatment plants.
- Bacterial degradation of moxifloxacin in the presence of acetate as a bulk substratePublication . Carvalho, M. F.; Maia, A. S.; Tiritan, M. E.; Castro, P. M. L.Fluoroquinolones constitute a group of emerging pollutants and their occurrence in different environmental compartments is becoming object of increasing public concern due to their ecotoxicological effects and the potential to develop resistant bacteria. This study aimed to investigate the biodegradation of moxifloxacin (MOX), for which studies in the literature are very scarce. An activated sludge (AS) consortium and three bacterial strains able to degrade fluoroaromatic compounds e strains F11, FP1 and S2 e were tested. Biodegradation studies were conducted using acetate as a bulk carbon source. Strain F11 showed the highest biodegradation capacity, being able to completely consume and dehalogenate 7.5 mM of the target antibiotic when daily co-supplemented with acetate present as a readily degradable organic substrate in wastewaters. MOX could be used by strain F11 as a sole nitrogen source but the presence of an external nitrogen source in the culture medium was essential for complete biodegradation. Strain F11 was capable of completely consuming MOX in a range between 2 and 11 mM, although stoichiometric fluoride release was not obtained for the highest tested concentration. The antibacterial activity of residual MOX and of the metabolic products potentially resultant from the biodegradation process was investigated by agar diffusion tests, demonstrating that MOX biodegradation is associated with the elimination of the antibacterial properties of the target antibiotic and of the produced metabolites, which is an important result, as the activity of antibiotics and/or their metabolites in the environment, even at low levels, may lead to the development of resistant bacterial strains. Overall, the results obtained in this study suggest that strain F11 is a promising microorganism for the treatment of waters contaminated with MOX, where it could be used for bioaugmentation/bioremediation purposes. To the best of our knowledge, this is the first study reporting complete removal and dehalogenation of MOX by a single microorganism.
- Biodegradation of the fluorinated antibiotic moxifloxacinPublication . Carvalho, Maria F.; Maia, Alexandra; Tiritan, Maria E.; Castro, Paula M. L.
- Chiral analysis of pesticides and drugs of environmental concern: biodegradation and enantiomeric fractionPublication . Maia, Alexandra S.; Ribeiro, Ana R.; Castro, Paula M. L.; Tiritan, Maria ElizabethThe importance of stereochemistry for medicinal chemistry and pharmacology is well recognized and the dissimilar behavior of enantiomers is fully documented. Regarding the environment, the significance is equivalent since enantiomers of chiral organic pollutants can also differ in biodegradation processes and fate, as well as in ecotoxicity. This review comprises designed biodegradation studies of several chiral drugs and pesticides followed by enantioselective analytical methodologies to accurately measure the enantiomeric fraction (EF). The enantioselective monitoring of microcosms and laboratory-scale experiments with different environmental matrices is herein reported. Thus, this review focuses on the importance of evaluating the EF variation during biodegradation studies of chiral pharmaceuticals, drugs of abuse, and agrochemicals and has implications for the understanding of the environmental fate of chiral pollutants.
- Microbial degradation of pharmaceuticals followed by a simple HPLC-DAD methodPublication . Ribeiro, Ana R.; Goncalves, Virgínia M.F.; Maia, Alexandra S.; Carvalho, Maria F.; Castro, Paula M.L.; Tiritan, Maria E.The biodegradation of five pharmaceutical ingredients (PIs) of different therapeutic classes, namely antibiotics (trimethoprim, sulfametoxazole and ciprofloxacin), anti-inflammatory (diclofenac) and anti-epileptic (carbamazepine), by two distinct microbial consortia, was investigated. For the monitoring of biodegradation assays, a simple HPLC-DAD (High Performance Liquid Chromatography – Diode Array Detector) method was developed and validated. The separation of the target pharmaceuticals was performed using an environmental friendly mobile phase in a gradient mode of 0.1% triethylamine (TEA) in water acidified at pH 2.23 with trifluoroacetic acid (TFAA) and ethanol as organic solvent. The method revealed to be selective, linear and precise in the range of 1.0 to 30.0 μg/mL for all PIs. Biodegradation assays were performed using activated sludge and a bacterial consortium (able to degrade fluoroaromatic compounds) supplemented with the target PIs at a final concentration of 25 μg/mL. The results revealed that activated sludge removed the target compounds more efficiently than the bacterial consortium.
- Integrated liquid chromatography method in enantioselective studies: biodegradation of ofloxacin by an activated sludge consortiumPublication . Maia, Alexandra S.; Castro, Paula M. L.; Tiritan, M. E.tOfloxacin is a chiral fluoroquinolone commercialized as racemate and as its enantiomerically pure formlevofloxacin. This work presents an integrated liquid chromatography (LC) method with fluorescencedetection (FD) and exact mass spectrometry (EMS) developed to assess the enantiomeric biodegradationof ofloxacin and levofloxacin in laboratory-scale microcosms. The optimized enantioseparation condi-tions were achieved using a macrocyclic antibiotic ristocetin A-bonded CSP (150 × 2.1 mm i.d.; particlesize 5 m) under reversed-phase elution mode. The method was validated using a mineral salts mediumas matrix and presented selectivity and linearity over a concentration range from 5 g L−1(quantificationlimit) to 350 g L−1for each enantiomer. The method was successfully applied to evaluate biodegrada-tion of ofloxacin enantiomers at 250 g L−1by an activated sludge inoculum. Ofloxacin (racemic mixture)and (S)-enantiomer (levofloxacin) were degraded up to 58 and 52%, respectively. An additional degrad-able carbon source, acetate, enhanced biodegradation up to 23%. (S)-enantiomer presented the highestextent of degradation (66.8%) when ofloxacin was supplied along with acetate. Results indicated slightlyhigher biodegradation extents for the (S)-enantiomer when supplementation was done with ofloxacin.Degradation occurred faster in the first 3 days and proceeded slowly until the end of the assays. Thechromatographic results from LC-FD suggested the formation of the (R)-enantiomer during levofloxacinbiodegradation which was confirmed by LC–MS with a LTQ Orbitrap XL.
- Enantioselective Determination of Fluoxetine and Norfluoxetine in WastewaterPublication . Ribeiro, Ana R.; Maia, Alexandra S.; Moreira, Irina S.; Afonso, Carlos; Castro, Paula M.L.; Tiritan, Maria E.Microbial degradation of chiral compounds during wastewater treatment processes can be enantioselective and needs chiral analytical methodology to discriminate the biodegradation of both enantiomers. An enantioselective HPLC-FD method was developed and validated to monitor the degradation of fluoxetine (FLX) enantiomers by wastewater and the possible formation of its metabolite norfluoxetine (NFLX). The Solid Phase Extraction (SPE) of 50 mL of wastewater samples on 500 mg Oasis MCX cartridges was followed by the HPLC analysis using a Chirobiotic V chiral stationary phase under reversed mode. The developed method wasvalidated within the wastewater effluent used in microcosms laboratory assays. The chiral SPE-HPLC-FD method demonstrated to be selective, linear, sensitive, accurate and precise to quantify the enantiomers of FLX and of its metabolites NFLX in wastewaters. The limits of detection (0.8-2.0 ng mL -1 ) and quantification (2.0 – 4.0 ng mL -1 ) were adequate to monitoring the degradation assays at environmental level. The method proved to be robust to follow the biodegradation assays using real wastewater samplesspiked with FLX, during 46 days. To the best of our knowledge, this is the first reportof simultaneous separation of FLX and NFLX enantiomers using a Chirobiotic V and the application of the validated method to the enantioselective degradation by wastewater
- Degradation of Fluoroquinolone Antibiotics and Identification of Metabolites/Transformation Products by LC-MS/MSPublication . Maia, Alexandra S.; Ribeiro, Ana R.; Amorim, Catarina L.; Barreiro, Juliana C.; Cass, Quezia B.; Castro, Paula M.L.; Tiritan, Maria E.Antibiotics are a therapeutic class widely found inenvironmental matrices and extensively studied due to its persistence and implications for multi-resistant bacteria development. Degradation of four fluoroquinolone antibiotics, namely Ofloxacin (OFL), Norfloxacin (NOR), Ciprofloxacin (CPF) and Moxifloxacin (MOX), at 10 mg L-1 using a mixed bacterial culture, was assessed for 60 days. The assays were followed by a developed and validated analytical method of HPLC with Fluorescence Detection using a Luna PFP (2) 3µm column. The optimized conditions allowed picturing metabolites/transformation products formation and accumulation during the process, stating an incomplete mineralization, also shown byfluoride release. OFL and MOX presented the highest (98.3%) and the lowest (80.5%) extent of degradation after 19 days of assay, respectively. Some of these intermediate compounds were identified by LCMS/MS in selected degradation samples. Most of the intermediates were already described as biodegradation and/or photodegradationproducts in different conditions, but new and/or unknown metabolites were also present.